Stevanato Group (NYSE:STVN) Director Purchases €326,750.00 in Stock

Stevanato Group S.p.A. (NYSE:STVN) Director Donald Morel, Jr. purchased 25,000 shares of the firm’s stock in a transaction that occurred on Friday, November 6th. The shares were acquired at an average cost of €13.07 per share, for a total transaction of €326,750.00. Following the purchase, the director owned 62,424 shares of the company’s stock, valued at €815,881.68. This represents a 66.80% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Stevanato Group Price Performance

STVN stock traded down €0.29 during trading on Tuesday, hitting €13.44. 476,532 shares of the company’s stock traded hands, compared to its average volume of 559,780. Stevanato Group S.p.A. has a 52 week low of €12.05 and a 52 week high of €25.45. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.08 and a current ratio of 1.73. The business has a fifty day simple moving average of €19.65 and a 200 day simple moving average of €17.98. The stock has a market capitalization of $4.07 billion, a price-to-earnings ratio of 23.16, a P/E/G ratio of 1.15 and a beta of 0.80.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported €0.16 EPS for the quarter, missing analysts’ consensus estimates of €0.17 by (€0.01). Stevanato Group had a return on equity of 10.51% and a net margin of 11.24%. The business had revenue of €326.06 million during the quarter. As a group, research analysts expect that Stevanato Group S.p.A. will post 0.67 EPS for the current fiscal year.

Institutional Trading of Stevanato Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in STVN. First Bank & Trust grew its stake in shares of Stevanato Group by 3.4% during the second quarter. First Bank & Trust now owns 18,417 shares of the company’s stock valued at $333,000 after buying an additional 603 shares during the last quarter. Fifth Third Bancorp raised its holdings in shares of Stevanato Group by 22.6% in the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after buying an additional 773 shares during the period. PineStone Asset Management Inc. grew its position in Stevanato Group by 8.4% in the 3rd quarter. PineStone Asset Management Inc. now owns 41,335 shares of the company’s stock valued at $867,000 after acquiring an additional 3,200 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new stake in Stevanato Group in the second quarter worth $59,000. Finally, Diversify Wealth Management LLC increased its stake in Stevanato Group by 23.9% in the first quarter. Diversify Wealth Management LLC now owns 18,353 shares of the company’s stock worth $252,000 after purchasing an additional 3,543 shares during the period.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Citigroup reduced their price objective on Stevanato Group from $26.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, November 4th. William Blair lowered Stevanato Group from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 4th. Deutsche Bank Aktiengesellschaft started coverage on Stevanato Group in a report on Wednesday, October 7th. They issued a “hold” rating for the company. Weiss Ratings raised Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. Finally, UBS Group decreased their price target on Stevanato Group from $23.00 to $16.00 and set a “neutral” rating on the stock in a report on Wednesday, November 4th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.

About Stevanato Group

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.